Evidence map›Paper›PMID 20122714›Full record

ReviewActa histochemica2011

The cell giveth and the cell taketh away: an overview of Notch pathway activation by endocytic trafficking of ligands and receptors.

Emily B Pratt, Jill S Wentzell, Julia E Maxson, Lauren Courter, Dennis Hazelett, Jan L Christian

Abstract readReview
In one paragraph

Review in Acta histochemica, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Clinical and Genetic Aspects of CADASIL.Frontiers in aging neuroscience · 2020
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Direct observation of proteolytic cleavage at the S2 site upon forced unfolding of the Notch negative regulatory region.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  10. Notch signaling and cardiac repair.Journal of molecular and cellular cardiology · 2012
    Review
  11. Delta-like 1-Lysine613 regulates notch signaling.Biochimica et biophysica acta · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Emily B PrattCenter for Research on Occupational and Environmental Toxicology, School of Medicine, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239-3098, USA.
Jill S Wentzell
Julia E Maxson
Lauren Courter
Dennis Hazelett
Jan L Christian
Oregon Health & Science University · US

Funding

EMBRYONIC SIGNALING REGULATION BY PROPROTEIN CONVERTASESR01HD037976 · NICHD · UNIVERSITY OF UTAH · PI CHRISTIAN, JAN L · 1999 to 2012
$2.5M
Basic research training in embryonic developmentT32HD049309 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI BARR-GILLESPIE, PETER GORDON · 2006 to 2010
$1.8M
SUR1 mutations and Subunit Associations in ATP-Sensitive Potassium ChannelsF30DK081305 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI PRATT, EMILY B · 2008 to 2011
$178k
Role of Sortlin in regulating proteolytic activation of BMP4 during embryogenesisR03HD058841 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI CHRISTIAN, JAN L · 2008 to 2009
$154k
NICHD NIH HHS R01 HD037976NICHD NIH HHS R01HD37976NICHD NIH HHS R03 HD058841NICHD NIH HHS R03HD058841NICHD NIH HHS T32 HD049309NIDDK NIH HHS 5F30DK081305NIDDK NIH HHS F30 DK081305
6 · The paper itself

Abstract

Notch signaling is firmly established as a form of cell-to-cell communication that is critical throughout development. Dysregulation of Notch has been linked to cancer and developmental disorders, making it an important target for therapeutic intervention. One aspect of this pathway that sets it apart from others is its apparent reliance on endocytosis by signal-sending and signal-receiving cells. The subtle details of endocytosis-mediated molecular processing within both ligand- and receptor-presenting cells that are required for the Notch signal to maintain fidelity remain unclear. The endosomal system has long been known to play an important role in terminating signal transduction by directing lysosomal trafficking and degradation of cell surface receptors. More recently, endocytic trafficking has also been shown to be critical for activation of signaling. This review highlights four models of endocytic processing in the context of the Notch pathway. In ligand-presenting cells, endocytosis may be required for pre-processing of ligands to make them competent for interaction with Notch receptors and/or for exerting a pulling force on the ligand/Notch complex. In receptor-presenting cells, endocytosis may be a prerequisite for Notch cleavage and thus activation and/or it could be a means of limiting ligand-independent Notch activation. Recent advances in our understanding of how and why endocytosis of Notch receptors and ligands is required for activation and termination of signaling during normal development and in disease states are discussed.

Indexed as

EndocytosisLigandsAnimalsCell MembraneHumansModels, BiologicalProtein TransportReceptors, NotchSignal TransductionLigandsReceptors, Notch

Identifiers

PMID20122714
PMCPMC2939183
OpenAlexW2080186105

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.